Frankfurt - Delayed Quote EUR
Arcadia Biosciences, Inc. (17D.F)
3.7200
0.0000
(0.00%)
As of February 24 at 8:06:54 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,045
5,045
4,454
7,418
6,780
Cost of Revenue
2,963
2,963
2,174
6,101
8,708
Gross Profit
2,082
2,082
2,280
1,317
-1,928
Operating Expense
9,694
9,694
8,298
16,545
26,827
Operating Income
-7,612
-7,612
-6,018
-15,228
-28,755
Net Non Operating Interest Income Expense
782
782
695
289
-20
Other Income Expense
2,521
2,521
2
4,125
12,643
Pretax Income
-4,309
-4,309
-5,321
-10,814
-16,132
Tax Provision
8
8
8
14
2
Net Income Common Stockholders
-7,038
-7,038
-13,981
-15,376
-14,660
Diluted NI Available to Com Stockholders
-7,038
-7,038
-13,981
-15,376
-14,660
Basic EPS
-5.17
--
-11.29
-25.65
-27.60
Diluted EPS
-5.17
--
-11.29
-25.65
-27.60
Basic Average Shares
1,363.3030
--
1,236.9340
599.3890
532.0150
Diluted Average Shares
1,363.3030
--
1,236.9340
599.3890
532.0150
Total Operating Income as Reported
-3,648
-3,648
-6,102
-14,007
-35,526
Total Expenses
12,657
12,657
10,472
22,646
35,535
Net Income from Continuing & Discontinued Operation
-7,038
-7,038
-13,981
-15,376
-14,660
Normalized Income
-6,284.1000
-6,284.1000
-5,627.3600
-15,017.5700
-17,067.5400
Interest Income
782
782
695
289
--
Interest Expense
--
--
--
--
20
Net Interest Income
782
782
695
289
-20
EBIT
-7,612
-7,612
-6,018
-15,228
-28,755
EBITDA
-7,499
-7,499
-5,731
-14,749
-27,710
Reconciled Cost of Revenue
2,963
2,963
2,174
6,101
8,708
Reconciled Depreciation
113
113
287
479
1,045
Net Income from Continuing Operation Net Minority Interest
-4,317
-4,317
-5,324
-10,592
-14,660
Total Unusual Items Excluding Goodwill
2,490
2,490
384
4,430
3,298
Total Unusual Items
2,490
2,490
384
4,430
3,298
Normalized EBITDA
-9,989
-9,989
-6,115
-19,179
-31,008
Tax Rate for Calcs
0.0002
0.0002
0.0002
0
0.0003
Tax Effect of Unusual Items
522.9000
522.9000
80.6400
4.4300
890.4600
12/31/2021 - 5/26/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade